Antares Pharma Inc (NASDAQ:ATRS)

4.23
Delayed Data
As of 3:59pm ET
 -0.01 / -0.24%
Today’s Change
2.57
Today|||52-Week Range
5.07
+6.02%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$742.7M

Company Description

Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ.

Contact Information

Antares Pharma, Inc.
100 Princeton South
Ewing New Jersey 08628
P:(609) 359-3020
Investor Relations:
(609) 359-3016

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Robert F. ApplePresident, Chief Executive Officer & Director
Patrick MadsenSenior Vice President-Operations
Fred M. PowellChief Financial Officer & Executive Vice President
Jonathan S. JaffeVice President-Clinical & Medical Affairs
Peter C. RichardsonChief Medical Officer & Executive VP-Research